Chargement en cours...
Novel pharmacotherapies in diabetic retinopathy: Current status and what's in the horizon?
The blood–retinal barrier (BRB) alteration is the hallmark feature of diabetic retinopathy. Vascular endothelial growth factor (VEGF) is a potent vasopermeability factor that has been implicated in the pathogenesis of BRB alteration. Inflammation also plays a crucial role in this process with involv...
Enregistré dans:
| Publié dans: | Indian J Ophthalmol |
|---|---|
| Auteurs principaux: | , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
Medknow Publications & Media Pvt Ltd
2016
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4821120/ https://ncbi.nlm.nih.gov/pubmed/26953018 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4103/0301-4738.178154 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|